Latest Innovation News

Artrya Limited announces a strategic leadership reshuffle with co-founder John Konstantopoulos stepping into the CEO role as the company prepares for its U.S. commercial launch of the Salix® AI-powered platform.

Vinyl Group unveils its FY26 vision, shifting focus from growth to scalable profitability by leveraging AI-driven technology to connect millions of music creators, fans, and brands.

Biome Australia has reported record-breaking sales revenue for FY25, driven by strong domestic demand and promising international expansion. The company is on track to deliver its first full-year net profit and meet ambitious growth targets.

Copper Search Limited has secured two key exploration licences in South Australia's Eromanga Basin for Heavy Mineral Sands, setting the stage for a fully funded drilling campaign later this year. The company is also progressing copper-gold projects in New South Wales with government co-funding applications underway.

Norwood Systems has extended the repayment date on its key loan facility to July 31, 2025, with the principal reduced to $318,341 following significant repayments. This move supports the company’s ongoing growth initiatives, including its recent Optus contract win.

Sprintex Limited has extended convertible note and loan agreements totaling A$2.85 million, bolstering financial flexibility as it prepares for a significant sales trial with the Van Drie Group that could unlock over A$8.5 million in revenue.

Next Science Limited has agreed to sell most of its assets to Demetra Holdings for US$50 million, with plans to return an estimated US$30 million net proceeds to shareholders pending approval.

Raptis Group Limited has appointed Russell Garnett as its new CEO and Managing Director, effective July 1, 2025, with a remuneration package heavily weighted towards long-term performance incentives.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Optiscan Imaging Ltd has commenced a landmark clinical study at Royal Melbourne Hospital, testing its cutting-edge InVue® and InForm™ devices to improve breast cancer surgery precision. The study aims to generate critical data for US FDA approval and could redefine surgical oncology workflows.

Electro Optic Systems has received A$60 million following the finalisation of a major contract, lifting its cash balance to approximately A$130 million as of June 30, 2025.

Magnetite Mines has increased its Razorback Iron Ore Project resource estimate and is advancing strategic partnerships, while early saline water testwork shows promise for green iron production.